Skip to main content
. 2019 Mar 4;11:207–216. doi: 10.2147/CLEP.S178003

Figure 1.

Figure 1

Flowchart of the study cohorts of patients with primary refractory or relapsed DLBCL in the LYFO database in Denmark, 2000–2015.

Note: *Response defined as complete or partial remission.

Abbreviations: CNS, central nervous system; DLBCL, diffuse large B-cell lymphoma.